Below are the 10 most expensive drugs in the U.S., along with their annual cost, based on length of therapy.
- Zolgensma (AveXis): $2,125,000
- Zokinvy (Eiger BioPharmaceuticals): $1,032,480
- Danyelza (Y-mAbs Therapeutics): $977,664
- Myalept (Aegerion Pharmaceuticals): $889,904
- Luxturna (Spark Therapeutics): $850,000
- Folotyn (Acrotech Biopharma): $793,870
- Brineura (BioMarin Pharmaceuticals): $730,340
- Blincyto (Amgen): $712,672
- Ravicti (Horizon Therapeutics): $695,970
- Soliris (Alexion Pharmaceuticals): $678,392
More articles on pharmacy:
Amgen acquires cancer drugmaker for $1.9B
Moderna vaccine causing delayed rash in some recipients, small study says
AmerisourceBergen awards CEO $14.3M pay package despite $6.6B opioid settlement
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
